Pre- and postoperative management of patients receiving rituximab therapy;Prä- und postoperatives Management von Patienten unter Rituximab-Therapie

Aktuelle Rheumatologie

Volumn 35, Issue 6, 2010, Pages 386-388

  Kaufmann, D ^a   Arbogast, M ^b  

^a Klinik Fr Internistische Rheumatologie   (Germany)

^b Rheumazentrum   (Germany)

Author keywords

operation; rheumatoid arthritis; rituximab

Indexed keywords

RITUXIMAB;

ARTICLE; HUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT;

EID: 78650368922     PISSN: 0341051X     EISSN: 14389940     Source Type: Journal    
DOI: 10.1055/s-0030-1267181     Document Type: Article

References (12)

1. Cohen SB, Emery P, Greenwald MW, etal. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Results of a multicenter, randomized, double-blind, placebo-controlled phase III trial evaluating primary efficacy and safety at 24 weeks. Arthritis Rheum 2006 54 2793-2806
2. Keystone E, Fleischmann RM, Emery P, etal. Repeated treatment courses of rituximab in rheumatoid arthritis: sustained efficacy in patients with an inadequate response to one or more TNF inhibitors. Ann Rheum Dis 2007 66 Suppl. II 432
3. Bibbo C, Goldberg JW. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 2004 May 25 5 331-335
4. Busti AJ, Hooper JS, Amaya CJ, etal. Effects of perioperative antiinflammatory and immunmodulating therapy on surgical wound healing. Pharmacotherapy 2005 Nov 25 11 1566-1591
5. Den Broeder AA, Creemers MC, Fransen J, etal. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol 2007 34 689-695
6. Fuerst M, Mohl H, Baumgartel K, etal. Leflunonomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Rheumatol Int 2006 26 1138-1142
7. Grennan DM, Gray J, Loudon J, etal. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001 60 214-217
8. Jain A, Witbreuk M, Ball C, etal. Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J Hand Surg (Am) 2002 27 449-455
9. Rosandich PA, Kelley JT 3rd, Conn DL. Perioperative management of patients with rheumatoid arthritis in the era of biologic response modifiers. Curr Opin Rheumatol 2004 May 16 3 192-198
10. Ruyssen-Witrand A, Gossec L, Salliot C, etal. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol 2007 May-Jun 25 3 430-436
11. Härtle P, Fleck M. Immunsuppressive Therapie bei Patienten mit rheumatischen Erkrankungen im Vorfeld elektiver Operationen. Arzneimitteltherapie 2008 26 332-336
12. Saech J, Maizus K, Owczarczyk K, etal. Kein erhhtes Risiko fr postoperative Infektionen unter Rituximab bei Patienten mit RA. Poster, Deutscher Rheumatologenkongress Kln 2009